Opinion|Videos|April 22, 2025

The Role of Prescription Digital Therapeutics in the Schizophrenia Treatment Landscape

Gus Alva, MD, discusses how he will be examining notable challenges in schizophrenia care, including access issues, and exploring the potential role of prescription digital therapeutics in addressing these gaps.

Episodes in this series

Summary for Physicians: Introduction to Prescription Digital Therapeutics in Schizophrenia Care

Presenter: Gus Alva, MD

Series Overview: This PsychView video series from Psychiatric Times examines prescription digital therapeutics (PDTs) as part of a multimodal treatment approach for schizophrenia.

Future Episodes: The series will feature discussions focusing on:

  • How PDTs can address gaps in provider care
  • The ways PDTs can help patients become active stakeholders in their treatment
  • Potential solutions to challenges in schizophrenia care, including access issues

Newsletter

Receive trusted psychiatric news, expert analysis, and clinical insights — subscribe today to support your practice and your patients.

Subscribe Now!

Related Content

Latest CME

(CME Track) SoCal Psych 2025: Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia
Video

(CME Track) SoCal Psych 2025: Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia

Gus Alva, MD, DFAPA; Ilan Melnick, MD

View more
Live Expert Illustrations & Commentary™: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder
Video

Live Expert Illustrations & Commentary™: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder

Jason Kellogg, MD; Gus Alva, MD, DFAPA; Melanie Barrett, MD; Yvette Elpidio, MSN, FNP-C

View more